GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
rescinnamine is an approved drug
Compound class:
Natural product
Comment: Rescinnamine is an angiotensin-converting enzyme (ACE) inhibitor. There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Natural product |
| Approved drug? | Yes. |
IUPAC Name ![]() |
| methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 683 | rescinnamine |
Database Links ![]() |
|
| CAS Registry No. | 24815-24-5 |
| ChEBI | CHEBI:28572 |
| ChEMBL Ligand | CHEMBL1668 |
| DrugBank Ligand | DB01180 |
| DrugCentral Ligand | 2369 |
| GtoPdb PubChem SID | 178103676 |
| PubChem CID | 5280954 |
| Search Google for chemical match using the InChIKey | SZLZWPPUNLXJEA-QEGASFHISA-N |
| Search Google for chemicals with the same backbone | SZLZWPPUNLXJEA |
| Search PubMed clinical trials | rescinnamine |
| Search PubMed titles | rescinnamine |
| Search PubMed titles/abstracts | rescinnamine |
| UniChem Compound Search for chemical match using the InChIKey | SZLZWPPUNLXJEA-QEGASFHISA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | SZLZWPPUNLXJEA-QEGASFHISA-N |
| Wikipedia | Rescinnamine |